YusufS, HawkenS, OunpuuS, et al.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet, 2004; 364:937–952.
2.
BenjaminEJ, MuntnerP, AlonsoA, et al.Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation, 2019; 139:e56–e528.
3.
MoscaL, HammondG, Mochari-GreenbergerH, et al.Fifteen-year trends in awareness of heart disease in women: Results of a 2012 American Heart Association national survey. Circulation, 2013; 127:1254–1263, e1251–1229.
4.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med, 1997; 157:2413–2446.
5.
ChobanianAV, BakrisGL, BlackHR, et al.Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003; 42:1206–1252.
6.
WheltonPK, CareyRM, AronowWS, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2018; 71:e127–e248.
7.
GroupSR, WrightJTJr., WilliamsonJD, et al.A randomized trial of intensive versus standard blood-pressure control. N Engl J Med, 2015; 373:2103–2116.
8.
SavaR, ChenY, SmithS, et al.Risk and blood pressure control rates across the spectrum of coronary artery disease in hypertensive women—an analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST). J Women's Health, 2020; 29:158–166.
9.
PepineCJ, HandbergEM, Cooper-DeHoffRM, et al.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA, 2003; 290:2805–2816.
10.
GulatiM, Cooper-DeHoffRM, McClureC, et al.Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med, 2009; 169:843–850.
11.
OlesenKKW, MadsenM, LipGYH, et al.Coronary artery disease and risk of adverse cardiac events and stroke. Eur J Clin Invest, 2017; 47:819–828.
